CSIMarket
 


Royalty Pharma Plc  (RPRX)
Other Ticker:  
 

RPRX's ROA over the last five Years

Annual Return on Assets, Asset and Income Growth


Return On Assets (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2016)
2016
Y / Y Total Assets Change -34.74 % -9.08 % 5.16 % 38227.68 % -59.24 %
Y / Y Net Income Change 638.96 % -81.46 % -27.07 % - -
Return On Assets 81.18 % 7.17 % 35.16 % 50.71 % -


You need to upgrade your Flash Player


Roa Comment
In (Dec 31 2023) ROA improved to 81.18 % compare to previous year, due to annual net income growth of 638.96 % to $1,700.09 millions, and due to decline of value in Royalty Pharma Plc's assets by -34.74 % to $2,094.29 millions, compare to $2,094.29 a year before.


Financial Statements
Royalty Pharma Plc's Annual Assets $ 2,094 Millions Annual RPRX's Balance sheet
Royalty Pharma Plc's Annual Income $ 1,700 Millions Annual RPRX's Income Statement
Where are RPRX's Income coming from? Visit RPRX's Income by Segment





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com